Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 247-415-5 | CAS number: 26021-57-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro gene mutation study in bacteria
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 12 Dec 2003 to 19 Jan 2005
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 005
- Report date:
- 2005
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 471 (Bacterial Reverse Mutation Assay)
- Deviations:
- not specified
- GLP compliance:
- yes
- Type of assay:
- bacterial reverse mutation assay
Test material
- Reference substance name:
- 3,4-dihydro-2H-1,4-benzoxazin-6-ol
- EC Number:
- 247-415-5
- EC Name:
- 3,4-dihydro-2H-1,4-benzoxazin-6-ol
- Cas Number:
- 26021-57-8
- Molecular formula:
- C8H9NO2
- IUPAC Name:
- 3,4-dihydro-2H-1,4-benzoxazin-6-ol
- Test material form:
- solid: particulate/powder
Constituent 1
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Source and lot/batch number of test material: 0508918
- Expiration date of the lot/batch: September 2005 (the expiry date specified in the Study plan (September 2004)
was reviewed in the final analytical certificate)
- Purity test date: 98.3%
STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: at +4°C, protected from light and under nitrogen gas
- Stability under storage conditions: not specified
- Solubility and stability of the test substance in the solvent/dispersant/vehicle/test medium: The test item dosage forms were prepared extemporaneously under nitrogen atmosphere and were stored at room temperature, protected from light (using an aluminium foil) and under nitrogen atmosphere until treatment, for a maximum period of 4 hours according to stability results obtained in CIT/Study No. 26976 AHS.
TREATMENT OF TEST MATERIAL PRIOR TO TESTING
- Treatment of test material prior to testing: The test item was dissolved in the vehicle at a concentration of 50 mg/mL for the preliminary toxicity test and both mutagenicity experiments.
- Preliminary purification step (if any): no
Method
- Target gene:
- Each strain derived from Salmonella typhimurium LT 2 contains one mutation in the histidine operon, resulting in a requirement for histidine.
In addition, to increase their sensitivity to mutagenic items, further mutations have been added:
• the rfa mutation causes partial loss of the lipopolysaccharide barrier that coats the surface of the bacteria and increases permeability to large molecules that do not penetrate the normal bacteria cell wall,
• the uvrB mutation is a deletion of a gene coding for the DNA excision repair system, which renders the bacteria unable to use this repair mechanism to remove the damaged DNA,
• the addition of the plasmid pKM 101 to strains TA 98, TA 100 and TA 102 enhances their sensitivity of detection to some mutagens,
• in case of TA 102 strain, the histidine mutation is located on the multicopy plasmid pAQ1.
The TA 1535, TA 100 and TA 102 strains are reverted by base-pair substitution mutagens and the TA 1537 and TA 98 strains by frameshift mutagens. In addition, the TA 102 strain detects oxidative mutagens.
Species / strain
- Species / strain / cell type:
- S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and TA 102
- Details on mammalian cell type (if applicable):
- CELLS USED
- Type and source of cells: five strains of Salmonella typhimurium (a): TA 1535, TA 1537, TA 98, TA 100 and TA 102 were supplied by B.N. Ames' Laboratory (University of California, Berkeley, USA)
- Suitability of cells: They are stored in a cryoprotective medium (1 mL nutrient broth and 0.09 mL dimethylsulfoxide) in liquid nitrogen.
- Normal cell cycle time (negative control): yes
Cultures : the day before treatment, cultures will be inoculated from frozen permanents: a scrape will be taken under sterile conditions and put into approximately 6 mL of nutrient broth. The nutrient broth will then be placed under agittaion in an incubator at 37°C for about 14 hours, to produce bacterial suspensions.
- Metabolic activation:
- with and without
- Metabolic activation system:
- Type and composition of metabolic activation system:
- source of S9 : The S9 mix consists of induced enzymatic systems contained in rat liver post-mitochondrial fraction (S9 fraction) and the cofactors necessary for their function. S9 fraction was purchased from Moltox (Molecular Toxicology, INC, Boone, NC 28607, USA) and obtained from the liver of rats treated with Aroclor 1254 (500 mg/kg) by the intraperitoneal route. Each batch of S9 is tested and validated by Moltox for its ability to activate benzo(a)pyrene and 2-anthramine (also known as 2-amino anthracene) to mutagenic intermediates.
The S9 fraction was preserved in sterile tubes at -80°C, until use.
- method of preparation of S9 mix: The S9 mix was prepared at + 4°C immediately before use and maintained at this temperature until added to the overlay agar.
- concentration or volume of S9 mix and S9 in the final culture medium : 38.5 mg/mL
The composition of S9 mix was as follows:
Ingredient
Glucose-6-phosphate: 5 mM
NADP: 4 mM
KCl 33: mM
MgCl2: 8 mM
Sodium phosphate buffer pH 7.4: 100 mM
S9 fraction, batch No. 1727, protein concentrations: 38.5 mg/mL 10% (v/v)
water: to volume - Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: DMSO
- Justification for choice of solvent/vehicle: The test item was freely soluble in the vehicle (DMSO) at 50 mg/mL.
Controls
- Untreated negative controls:
- not specified
- Negative solvent / vehicle controls:
- yes
- Positive controls:
- yes
- Positive control substance:
- 9-aminoacridine
- 2-nitrofluorene
- sodium azide
- mitomycin C
- other: 2-anthramine
- Details on test system and experimental conditions:
- NUMBER OF REPLICATIONS:
- Number of cultures per concentration: triplicate
- Number of independent experiments: 3: a preliminary test and 2 independent experiments
METHOD OF TREATMENT/ EXPOSURE:
- Cell density at seeding (if applicable):
- Test substance added in medium; in agar (plate incorporation); preincubation; in suspension; as impregnation on paper disk : The preliminary test, all experiments without S9 mix and the first experiment with S9 mix were performed according to the direct plate incorporation method. The second experiment with S9 mix was performed according to the preincubation method.
The direct plate incorporation method was performed as follows: test item solution (0.1 mL), S9 mix when required or phosphate buffer pH 7.4 (0.5 mL) and bacterial suspension (0.1 mL) were mixed with 2 mL of overlay agar (containing traces of the relevant aminoacid and biotin and maintained at 45°C). After rapid homogenization, the mixture was overlaid onto a Petri plate containing minimum medium.
TREATMENT AND HARVEST SCHEDULE:
- Preincubation period: The preincubation method was performed as follows: test item solution (0.1 mL), S9 mix (0.5 mL) and the bacterial suspension (0.1 mL) were incubated for 60 minutes at 37°C, under shaking, before adding the overlay agar and pouring onto the surface of a minimum agar plate.
After 48 to 72 hours of incubation at 37°C, revertants were scored with an automatic counter.
- Exposure duration/duration of treatment: after 48 to 72 h of incubation at 37°C, revertants will be scored with an automatic counter. Manual counting may be performed as needed.
- Rationale for test conditions:
- Treatment of results
In each experiment, for each strain and for each experimental point, the number of revertants per plate was scored. The individual results and the mean number of revertants, with the corresponding standard deviation and ratio (mutants obtained in the presence of the test item/mutants obtained in the presence of the vehicle), are presented in tabular form.
Acceptance criteria
This study is considered valid if the following criteria are fully met:
• the number of revertants in the vehicle controls is consistent with the historical data of the testing facility (appendix 2),
• the number of revertants in the positive controls is higher than that of the vehicle controls and is consistent with the historical data of the testing facility. - Evaluation criteria:
- A reproducible 2-fold increase (for the TA 98, TA 100 and TA 102 strains) or 3-fold increase (for the TA 1535 and TA 1537 strains) in the number of revertants compared with the vehicle controls, in any strain at any dose-level and/or evidence of a dose-relationship was considered as a positive result. Reference to historical data, or other considerations of biological relevance may also be taken into account in the evaluation of the data obtained.
Results and discussion
Test resultsopen allclose all
- Key result
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- without
- Genotoxicity:
- not determined
- Remarks:
- slight increase in the number of revertants but within the range of historical control and without reproducibility. coloration of agar observed
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Remarks:
- 5000 µg/plate
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not specified
- True negative controls validity:
- not specified
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- without
- Genotoxicity:
- not determined
- Remarks:
- slight increase in the number of revertants but within the range of historical control and without reproducibility. coloration of the agar observed
- Cytotoxicity / choice of top concentrations:
- cytotoxicity
- Remarks:
- at 5000 µg/plate
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not specified
- True negative controls validity:
- not specified
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 98
- Metabolic activation:
- with
- Genotoxicity:
- positive
- Remarks:
- dose-related and reproducible increase in the number of revertant colonies (up to 7.3-fold the vehicle control mean value).coloration of the agar observed
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Remarks:
- 5000 µg/plate
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not specified
- True negative controls validity:
- not specified
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 100
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Remarks:
- coloration of the agar observed
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Remarks:
- 5000 µg/plate
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not specified
- True negative controls validity:
- not specified
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1535
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Remarks:
- coloration of the agar observed
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Remarks:
- 5000 µg/plate
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not specified
- True negative controls validity:
- not specified
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 102
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Remarks:
- coloration of the agar observed
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Remarks:
- 5000 µg/plate
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not specified
- True negative controls validity:
- not specified
- Positive controls validity:
- valid
- Key result
- Species / strain:
- S. typhimurium TA 1537
- Metabolic activation:
- with and without
- Genotoxicity:
- negative
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Remarks:
- 5000 µg/plate
- Vehicle controls validity:
- valid
- Untreated negative controls validity:
- not specified
- True negative controls validity:
- not specified
- Positive controls validity:
- valid
- Additional information on results:
- TEST-SPECIFIC CONFOUNDING FACTORS
- Data on pH: The direct plate incorporation method was performed as follows: test item solution (0.1 mL), S9 mix when required or phosphate buffer pH 7.4 (0.5 mL)
RANGE-FINDING/SCREENING STUDIES (if applicable): To assess the toxicity of the test item to the bacteria, six dose-levels (one plate/dose-level) were tested in the TA 98, TA 100 and TA 102 strains, with and without S9 mix. The evaluation of the toxicity was performed on the basis of the observation of the decrease in the number of revertant colonies and/or a thinning of the bacterial lawn. The test item was freely soluble in the vehicle (DMSO) at 50 mg/mL.
Consequently, with a treatment volume of 100 μL/plate, the dose-levels were 10, 100, 500, 1000, 2500 and 5000 μg/plate.
A coloration of agar was noted in the Petri plates when scoring the revertants at dose-levels ≥ 2500 μg/plate.
A moderate precipitate was sometimes observed in the Petri plates when scoring the revertants at 5000 μg/plate.
No noteworthy toxicity was observed at any dose-level.
STUDY RESULTS
The number of revertants for the vehicle and positive controls was as specified in the acceptance criteria.
The study was therefore considered valid.
Since the test item was freely soluble and non toxic, the highest dose-level selected for the main test was 5000 μg/plate, according to the criteria specified in the international guidelines.
The selected treatment-levels were: 312.5, 625, 1250, 2500 and 5000 μg/plate, for all the strains in both experiments.
No precipitate was observed in the Petri plates when scoring the revertants at any dose-level. Except for a marked toxicity noted in the TA 98 strain without S9 mix at 5000 μg/plate, no toxicity was observed towards all the strains used, with and without S9 mix.
Some slight increases in the number of revertants were noted in the TA 1535 and TA 98 strains without S9 mix. However, since the numbers of revertants remained within the range of our historical control values and since these slight increases were not reproducible, they were considered not to be biologically relevant.
A dose-related and reproducible increase in the number of revertant colonies (up to 7.3-fold the vehicle control mean value) was observed in the TA 98 strain, with S9 mix.
- Genotoxicity results:
o Number of cells treated and sub-cultures for each cultures
o Number of cells plated in selective and non-selective medium
o Number of colonies in non-selective medium and number of resistant colonies in selective medium, and related mutant frequency
o When using the thymidine kinase gene on L5178Y cells: colony sizing for the negative and positive controls and if the test chemical is positive, and related mutant frequency. For the MLA, the GEF evaluation.
HISTORICAL CONTROL DATA (with ranges, means and standard deviation, and 95% control limits for the distribution as well as the number of data)
- Positive historical control data:
- Negative (solvent/vehicle) historical control data:
Any other information on results incl. tables
Table 1: Preliminary toxicity test Direct plate incorporation method
Revertant colony numbers per plate using strains TA 98, TA 100, TA 102
Strain |
Compound |
Dose level per plate |
S9 mix |
Mean revertant colony counts |
SD |
Ratio treated/solvent |
Individual revertant colony counts |
TA 98 |
DMSO |
|
- |
22 |
- |
|
22 |
test item |
10 µg
|
- |
25 |
- |
1.1 |
25 |
|
100 µg |
- |
29 |
- |
1.3 |
29 |
||
500 µg |
- |
26 |
- |
1.2 |
26 |
||
1000 µg |
- |
23 |
- |
1.0 |
23 |
||
2500 µg |
- |
25 |
- |
1.1 |
25 |
||
5000 µg |
- |
38 |
- |
1.7 |
38Mp+ Co |
||
DMSO |
|
+ |
43 |
- |
|
43 |
|
test item |
10 µg
|
+ |
24 |
- |
0.6 |
24 |
|
100 µg |
+ |
46 |
- |
1.1 |
46 |
||
500 µg |
+ |
103 |
- |
2.4 |
103 |
||
1000 µg |
+ |
145 |
- |
3.4 |
145 |
||
2500 µg |
+ |
320 |
- |
7.4 |
320 Co |
||
5000 µg |
+ |
232 |
- |
5.4 |
232Mp+ Co |
||
TA 100 |
DMSO |
|
- |
168 |
- |
|
168 |
test item |
10 µg
|
- |
132 |
- |
0.8 |
132 |
|
100 µg |
- |
174 |
- |
1.0 |
174 |
||
500 µg |
- |
166 |
- |
1.0 |
166 |
||
1000 µg |
- |
165 |
- |
1.0 |
165 |
||
2500 µg |
- |
183 |
- |
1.1 |
183 |
||
5000 µg |
- |
254 |
- |
1.5 |
254 Co +Mp |
||
DMSO |
|
+ |
159 |
- |
|
159 |
|
test item |
10 µg
|
+ |
102 |
- |
0.6 |
102 |
|
100 µg |
+ |
138 |
- |
0.9 |
138 |
||
500 µg |
+ |
152 |
- |
1.0 |
152 |
||
1000 µg |
+ |
210 |
- |
1.3 |
210 |
||
2500 µg |
+ |
205 |
- |
1.3 |
205 |
||
5000 µg |
+ |
181 |
- |
1.1 |
181 Co |
||
TA 102 |
DMSO |
|
- |
440 |
- |
|
440 |
test item |
10 µg
|
- |
432 |
- |
1.0 |
432 |
|
100 µg |
- |
405 |
- |
0.9 |
405 |
||
500 µg |
- |
486 |
- |
1.1 |
486 |
||
1000 µg |
- |
561 |
- |
1.3 |
561 |
||
2500 µg |
- |
496 |
- |
1.1 |
496 |
||
5000 µg |
- |
396 |
- |
0.9 |
396Mp+Co |
||
DMSO |
|
+ |
333 |
- |
|
333 |
|
test item |
10 µg
|
+ |
564 |
- |
1.7 |
564 |
|
100 µg |
+ |
254 |
- |
0.8 |
254 |
||
500 µg |
+ |
321 |
- |
1.0 |
321 |
||
1000 µg |
+ |
263 |
- |
0.8 |
263 |
||
2500 µg |
+ |
325 |
- |
1.0 |
325 |
||
5000 µg |
+ |
274 |
- |
0.8 |
274Mp+ Co |
Table 2: First experiment
Direct plate incorporation method
Revertant colony numbers per plate using strains TA 1535, TA 1537, TA 98, TA 100, TA 102
Strain |
Compound |
Dose level per plate |
S9 mix |
Mean revertant colony counts |
SD |
Ratio treated/solvent |
Individual revertant colony counts |
||||||||
TA 1535 |
DMSO |
|
- |
13 |
3 |
|
11,17,12 |
||||||||
test item |
312.5µg
|
- |
17 |
8 |
1.3 |
11,26,14 |
|||||||||
625 µg |
- |
19 |
1 |
1.4 |
19,18,20 |
||||||||||
1250 µg |
- |
29 |
10 |
2.2 |
19,30,38 |
||||||||||
2500 µg |
- |
45 |
3 |
3.4 |
47Co,46Co,41Co |
||||||||||
5000 µg |
- |
34 |
2 |
2.6 |
35Co,36Co,32Co |
||||||||||
NAN3 |
1 µg |
- |
649 |
39 |
48.7 |
683,658,606 |
|||||||||
DMSO |
|
+ |
14 |
4 |
|
10,14,17 |
|||||||||
test item |
312.5µg
|
+ |
7 |
1 |
0.5 |
8,7,6 |
|||||||||
625 µg |
+ |
15 |
3 |
1.1 |
18,14,12 |
||||||||||
1250 µg |
+ |
18 |
5 |
1.3 |
13,23,17 |
||||||||||
2500 µg |
+ |
25 |
7 |
1.8 |
31,18,26 |
||||||||||
5000 µg |
+ |
17 |
3 |
1.3 |
19Co,19Co,14Co |
||||||||||
2AM |
2 µg |
+ |
285 |
21 |
20.8 |
267,279,308 |
|||||||||
TA 1537 |
DMSO |
|
- |
7 |
4 |
|
11,7,4 |
||||||||
test item |
312.5µg
|
- |
6 |
1 |
0.9 |
7,5,7 |
|||||||||
625 µg |
- |
5 |
3 |
0.7 |
8,5,2 |
||||||||||
1250 µg |
- |
9 |
3 |
1.2 |
12,7,8 |
||||||||||
2500 µg |
- |
7 |
4 |
0.9 |
2Co, 10Co, 8Co |
||||||||||
5000 µg |
- |
6 |
1 |
0.8 |
5Co,7 Co, 5Co |
||||||||||
9AA |
50 µg |
- |
602 |
305 |
82.1 |
303,913,590 |
|||||||||
DMSO |
|
+ |
10 |
3 |
|
8,13,8 |
|||||||||
test item |
312.5µg
|
+ |
13 |
5 |
1.3 |
10,10,19 |
|||||||||
625 µg |
+ |
14 |
2 |
1.4 |
12,16,13 |
||||||||||
1250 µg |
+ |
14 |
3 |
1.4 |
11,17,14 |
||||||||||
2500 µg |
+ |
15 |
2 |
1.6 |
13,17,16 |
||||||||||
5000 µg |
+ |
8 |
2 |
0.8 |
7Co,6Co,10Co |
||||||||||
2AM |
2 µg |
+ |
102 |
10 |
10.5 |
91,110,104 |
|||||||||
TA 98 |
DMSO |
|
- |
17 |
6 |
|
24,13,14 |
||||||||
test item |
312.5µg
|
- |
20 |
0 |
1.2 |
20,20,20 |
|||||||||
625 µg |
- |
15 |
3 |
0.9 |
16,12,18 |
||||||||||
1250 µg |
- |
26 |
7 |
1.5 |
29,31,18 |
||||||||||
2500 µg |
- |
23 |
7 |
1.3 |
31Co,17Co,20Co |
||||||||||
5000 µg |
- |
2 |
2 |
0.1 |
0Co+St, 4Co+St, 2Co+St |
||||||||||
2NF |
0.5 µg |
- |
346 |
1 |
20.4 |
347,345,346 |
|||||||||
DMSO |
|
+ |
27 |
4 |
|
24,32,26 |
|||||||||
test item |
312.5µg
|
+ |
57 |
5 |
2.1 |
52,57,62 |
|||||||||
625 µg |
+ |
90 |
2 |
3.3 |
89,92,90 |
||||||||||
1250 µg |
+ |
97 |
11 |
3.5 |
108,86,97 |
||||||||||
2500 µg |
+ |
200 |
28 |
7.3 |
231,192,176 |
||||||||||
5000 µg |
+ |
92 |
44 |
3.4 |
69Co, 65Co,143Co |
||||||||||
2AM |
2 µg |
+ |
926 |
114 |
33.9 |
808,1036,934 |
|||||||||
TA 100 |
DMSO |
|
- |
131 |
8 |
|
133,137,122 |
||||||||
test item |
312.5µg
|
- |
146 |
11 |
1.1 |
134,153,152 |
|||||||||
625 µg |
- |
148 |
16 |
1.1 |
129,159,155 |
||||||||||
1250 µg |
- |
159 |
23 |
1.2 |
149,143,186 |
||||||||||
2500 µg |
- |
160 |
6 |
1.2 |
159Co,166Co,155Co |
||||||||||
5000 µg |
- |
145 |
20 |
1.1 |
133Co,133Co,168Co |
||||||||||
NAN3 |
1µg |
- |
751 |
46 |
5.7 |
726,723,804 |
|||||||||
DMSO |
|
+ |
105 |
8 |
|
98,104,113 |
|||||||||
test item |
312.5µg
|
+ |
117 |
19 |
1.1 |
95,129,126 |
|||||||||
625 µg |
+ |
115 |
22 |
1.1 |
104,141,101 |
||||||||||
1250 µg |
+ |
113 |
8 |
1.1 |
110,108,122 |
||||||||||
2500 µg |
+ |
96 |
13 |
0.9 |
84,95,109 |
||||||||||
5000 µg |
+ |
103 |
21 |
1.0 |
79Co,114Co,116Co |
||||||||||
2AM |
2 µg |
+ |
490 |
38 |
4.7 |
460,533,477 |
|||||||||
TA 102 |
DMSO |
|
- |
367 |
26 |
|
387,337,376 |
||||||||
test item |
312.5µg
|
- |
360 |
4 |
1.0 |
362,355,363 |
|||||||||
625 µg |
- |
346 |
58 |
0.9 |
304,322,412 |
||||||||||
1250 µg |
- |
376 |
53 |
1.0 |
426,321,382 |
||||||||||
2500 µg |
- |
341 |
33 |
0.9 |
364Co,355Co,303Co |
||||||||||
5000 µg |
- |
354 |
21 |
1.0 |
377Co,349Co, 337Co |
||||||||||
MMC |
0.5 µg |
- |
2106 |
109 |
5.7 |
2149,2188,1982 |
|||||||||
DMSO |
|
+ |
350 |
61 |
|
383,387,279 |
|||||||||
test item |
312.5µg
|
+ |
437 |
87 |
1.3 |
485,490,337 |
|||||||||
625 µg |
+ |
393 |
65 |
1.1 |
449,407,322 |
||||||||||
1250 µg |
+ |
468 |
62 |
1.3 |
418,448,537 |
||||||||||
2500 µg |
+ |
405 |
23 |
1.2 |
405,383,428 |
||||||||||
5000 µg |
+ |
402 |
15 |
1.1 |
418Co,399Co,388Co |
||||||||||
2AM |
10 µg |
+ |
1642 |
267 |
4.7 |
1910,1640,1376 |
SD: Standard deviation
- : Absence of S9
+ :Presence of S9
Co :coloration of agar
St :strong toxicity
Table 3: Second experiment
Direct plate incorporation method (without S9 mix) and preincubation method (with S9 mix)
Revertant colony numbers per plate using strains TA 1535, TA 1537, TA 98, TA 100, TA 102
Strain |
Compound |
Dose level per plate |
S9 mix |
Mean revertant colony counts |
SD |
Ratio treated/solvent |
Individual revertant colony counts |
TA 1535 |
DMSO |
|
- |
15 |
1 |
|
14,16,16 |
test item |
312.5µg
|
- |
17 |
4 |
1.1 |
22,14,16 |
|
625 µg |
- |
11 |
6 |
0.7 |
11,17,5 |
||
1250 µg |
- |
18 |
3 |
1.2 |
20,20,14 |
||
2500 µg |
- |
34 |
4 |
2.2 |
34Co,30Co,37Co |
||
5000 µg |
- |
32 |
10 |
2.1 |
42Co,22Co,31Co |
||
NAN3 |
1 µg |
- |
463 |
12 |
30.2 |
450,466,473 |
|
DMSO |
|
+ |
14 |
3 |
|
10,16,16 |
|
test item |
312.5µg
|
+ |
11 |
3 |
0.8 |
7,13,13 |
|
625 µg |
+ |
14 |
3 |
1.0 |
12,12,17 |
||
1250 µg |
+ |
18 |
5 |
1.3 |
12,22,19 |
||
2500 µg |
+ |
22 |
8 |
1.6 |
14,24,29 |
||
5000 µg |
+ |
39 |
9 |
2.8 |
40Co,47Co,30Co |
||
2AM |
2 µg |
+ |
153 |
17 |
10.9 |
171,138,150 |
|
TA 1537 |
DMSO |
|
- |
6 |
2 |
|
5,5,8 |
test item |
312.5µg
|
- |
5 |
4 |
0.8 |
8,1,5 |
|
625 µg |
- |
7 |
4 |
1.2 |
6,4,11 |
||
1250 µg |
- |
6 |
1 |
1.1 |
6,6,7 |
||
2500 µg |
- |
7 |
3 |
1.2 |
5Co,6Co,11Co |
||
5000 µg |
- |
12 |
6 |
1.9 |
5Co,17Co,13Co |
||
9AA |
50 µg |
- |
476 |
123 |
79.4 |
511,578,340 |
|
DMSO |
|
+ |
7 |
3 |
|
10,4,6 |
|
test item |
312.5µg
|
+ |
12 |
6 |
1.8 |
6,17,13 |
|
625 µg |
+ |
10 |
3 |
1.3 |
7,12,12 |
||
1250 µg |
+ |
7 |
1 |
1.1 |
7,8,7 |
||
2500 µg |
+ |
13 |
7 |
2.0 |
7,13,20 |
||
5000 µg |
+ |
13 |
5 |
1.9 |
14Co,17Co,7Co |
||
2AM |
2 µg |
+ |
121 |
10 |
18.2 |
114,133,117 |
|
TA 98 |
DMSO |
|
- |
10 |
6 |
|
5,7,17 |
test item |
312.5µg
|
- |
8 |
4 |
0.9 |
12,8,5 |
|
625 µg |
- |
12 |
5 |
1.2 |
11,7,17 |
||
1250 µg |
- |
20 |
5 |
2.1 |
25,19,16 |
||
2500 µg |
- |
19 |
5 |
2.0 |
14Co,24Co,19Co |
||
5000 µg |
- |
6 |
3 |
0.6 |
2Co+St, 7Co+St,8Co+St |
||
2NF |
0.5 µg |
- |
274 |
34 |
28.4 |
281,237,305 |
|
DMSO |
|
+ |
23 |
3 |
|
25,24,20 |
|
test item |
312.5µg
|
+ |
43 |
11 |
1.9 |
31,46,52 |
|
625 µg |
+ |
62 |
2 |
2.7 |
60,63,63 |
||
1250 µg |
+ |
130 |
23 |
5.6 |
145,141,103 |
||
2500 µg |
+ |
124 |
19 |
5.4 |
103,128,140 |
||
5000 µg |
+ |
76 |
7 |
3.3 |
73Co,71Co,84Co |
||
2AM |
2 µg |
+ |
1750 |
76.1 |
76.1 |
1801,1880,1568 |
|
TA 100 |
DMSO |
|
- |
159 |
19 |
|
172,168,138 |
test item |
312.5µg
|
- |
165 |
11 |
1.0 |
162,177,156 |
|
625 µg |
- |
165 |
6 |
1.0 |
164,172,160 |
||
1250 µg |
- |
160 |
12 |
1.0 |
163,170,146 |
||
2500 µg |
- |
221 |
12 |
1.4 |
223Co,232Co,208Co |
||
5000 µg |
- |
182 |
10 |
1.1 |
170Co, 187Co,189Co |
||
NAN3 |
1µg |
- |
430 |
11 |
2.7 |
419,440,432 |
|
DMSO |
|
+ |
187 |
28 |
|
171,171,219 |
|
test item |
312.5µg
|
+ |
146 |
5 |
0.8 |
150,147,140 |
|
625 µg |
+ |
163 |
36 |
0.9 |
121,187,181 |
||
1250 µg |
+ |
157 |
27 |
0.8 |
186,133,153 |
||
2500 µg |
+ |
183 |
7 |
1.0 |
176,184,190 |
||
5000 µg |
+ |
189 |
38 |
1.0 |
152Co,187Co,228Co |
||
2AM |
2 µg |
+ |
1028 |
102 |
5.5 |
1146,963,976 |
|
TA 102 |
DMSO |
|
- |
352 |
30 |
|
320,355,380 |
test item |
312.5µg |
- |
289 |
31 |
0.8 |
317,255,295 |
|
625 µg |
- |
287 |
69 |
0.8 |
222,281,359 |
||
1250 µg |
- |
268 |
13 |
0.8 |
283,263,259 |
||
2500 µg |
- |
298 |
20 |
0.8 |
309Co;311Co,275Co |
||
5000 µg |
- |
239 |
18 |
0.7 |
218Co,252Co,247Co |
||
MMC |
0.5 µg |
- |
1166 |
102 |
3.3 |
1260,1058,1180 |
|
DMSO |
|
+ |
352 |
36 |
|
371,375,310 |
|
test item |
312.5µg
|
+ |
340 |
17 |
1.0 |
326,335,359 |
|
625 µg |
+ |
372 |
19 |
1.1 |
387,378,350 |
||
1250 µg |
+ |
337 |
43 |
1.0 |
328,384,299 |
||
2500 µg |
+ |
522 |
34 |
1.5 |
561,502,502 |
||
5000 µg |
+ |
423 |
49 |
1.2 |
393Co,396Co,480Co |
||
2AM |
10 µg |
+ |
1858 |
3 |
5.3 |
1860,1860,1854 |
SD: Standard deviation
- : Absence of S9
+ :Presence of S9
Co :coloration of agar
St :strong toxicity
Applicant's summary and conclusion
- Conclusions:
- Under our experimental conditions, the test item Hydroxybenzomorpholine (A025) (batch No. 0508918) showed mutagenic activity in the bacterial reverse mutation test with Salmonella typhimurium TA 98 strain, with metabolic activation (S9 mix).
- Executive summary:
Hydroxybenzomorpholine was investigated for the induction of gene mutations in Salmonella typhimurium (Ames test). Liver S9 fraction from Aroclor 1254-induced rats was used as exogenous metabolic activation system. Test concentrations were based on the level of toxicity in a preliminary toxicity test with strains TA98, TA100 and TA102. Toxicity was evaluated on the basis of a reduction in the number of revertant colonies and/or thinning of the bacterial background lawn. Since hydroxybenzomorpholine was freely soluble and non toxic in this preliminary toxicity test, it was tested up to the prescribed maximum concentration of 5000
μg/plate. The preliminary toxicity test, experiment 1 and experiment 2 without S9 were performed with the direct plate incorporation method, experiment 2 with S9 according the preincubation method. Negative and positive controls were in accordance with the OECD guideline.
Results
Precipitation of hydroxybenzomorpholine was not observed. Marked toxicity was only seen in the TA98 strain without S9 at 5000 μg/plate. Toxicity was not noted towards all the other strains used without or with S9. A coloration of agar was noted at dose levels of 2500 μg/plate and above without S9 and at 5000 μg/plate with S9.
In experiment 1 without S9 a slight increase in the number of revertants was seen in the TA1535 strain. This increase was considered not biologically relevant since the number of revertants remained within the range of the historical control and the increase could not be confirmed in the second experiment.
A more or less dose related and reproducible increase was found in the number of revertants in strain TA 98 with S9.
Conclusion
Under the experimental conditions used hydroxybenzomorpholine was genotoxic (mutagenic) in the gene mutation tests in bacteria in strain TA98 in the presence of S9 metabolic activation.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.